Lead sponsor
Intra-Cellular Therapies, Inc.
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
2
Ongoing
902
Total enrollment
121
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
1
Phase 2
2
Phase 3
1
Trials by status
Recruiting
2
Completed
1
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseAlzheimer's diseasePh 2Recruiting370
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaAlzheimer's diseasePh 2Recruiting320
ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's DiseaseAlzheimer's diseasePh 3Terminated177
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With DementiaMMSE 26Ph 1/2Completed35